![](/img/cover-not-exists.png)
Editorial About: “A Prospective, Open-Label, Multicenter Phase II Trial of Neoadjuvant Therapy Using Full-Dose Gemcitabine and S-1 Concurrent with Radiation for Resectable Pancreatic Ductal Adenocarcinoma”
Schwartz, Patrick B., Uboha, Nataliya V., Weber, Sharon M.Language:
english
Journal:
Annals of Surgical Oncology
DOI:
10.1245/s10434-019-07737-6
Date:
August, 2019
File:
PDF, 201 KB
english, 2019